New Stock News | Mediterranean Resorts Files with the Hong Kong Stock Exchange
According to the Hong Kong Stock Exchange's disclosure on August 28, Mediterranean Resorts Group (referred to as: Mediterranean Resorts) has submitted a listing application to the main board of the Hong Kong Stock Exchange, with BNP Paribas, HSBC, and JPMorgan serving as its joint sponsors.
According to a disclosure by the Hong Kong Stock Exchange on August 28, the Mediterranean Resort Group (referred to as Mediterranean Resort) has submitted a listing application to the main board of the Hong Kong Stock Exchange, with BNP Paribas, HSBC, and JPMorgan serving as its joint sponsors. The prospectus indicates that Mediterranean Resort is a global high-quality vacation lifestyle group. Centered around the Club Med brand, the company operates high-end all-inclusive resorts and offers light asset vacation scene services, creating high-quality vacation experiences for customers worldwide. Club Med was founded in 1950 and is a pioneer and leader in the high-end all-inclusive resort industry, as well as one of the few high-end all-inclusive vacation brands to achieve a global presence. Leveraging over 75 years of brand heritage and global operational experience, the company has developed and operates a diverse range of high-end resort products covering mountain skiing and sunny beach areas through a sales network spanning over 40 countries and regions across six continents.
Related Articles

Musk solves the power generation bottleneck! SpaceX (SPCX.US) plans to produce its own "gas turbine blades."

New Stock News | Exegenesis Bio Inc. has once again submitted an application to the Hong Kong Stock Exchange, laying out its therapeutic pipelines for neurological and ophthalmological gene treatments.

Amid industry pressure, SUNSHINE INS (06963) delivers stable performance, highlighting the value of its high dividend and low valuation for quality development.
Musk solves the power generation bottleneck! SpaceX (SPCX.US) plans to produce its own "gas turbine blades."

New Stock News | Exegenesis Bio Inc. has once again submitted an application to the Hong Kong Stock Exchange, laying out its therapeutic pipelines for neurological and ophthalmological gene treatments.

Amid industry pressure, SUNSHINE INS (06963) delivers stable performance, highlighting the value of its high dividend and low valuation for quality development.

RECOMMEND





